BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  Utah Medical Products, Inc. Reports Financial Performance For Third Quarter 2015

  October 22, 2015

   · 

  22 min read
• Business

  LabCentral Founders and Cambridge BioLabs Plot a $150 Million Venture Fund For Biotech Startups

  October 22, 2015

   · 

  1 min read
• Policy

  Bill Would Ban Bayer’s Essure Contraceptive

  October 22, 2015

   · 

  1 min read
• Deals

  Strongbridge Biopharma Announces Closing Of Initial U.S. Public Offering

  October 22, 2015

   · 

  2 min read
• Deals

  PositiveID (PSID) Enters Into Agreement To Acquire Thermomedics And The Caregiver Non-Contact Thermometer

  October 22, 2015

   · 

  5 min read
• Drug Development

  CytoDyn Injects First Patient In Its Current Phase III Study

  October 22, 2015

   · 

  7 min read
• BioCapital

  Sucampo Closes $250 Million Credit Facility

  October 22, 2015

   · 

  3 min read
• Drug Development

  Cyclacel Pharmaceuticals, Inc. Doses First Patient In Phase I Trial Of Its Novel CDK2/9 Inhibitor, CYC065, For The Treatment Of Advanced Solid Tumors

  October 22, 2015

   · 

  6 min read
• Drug Development

  VBL Therapeutics Presents Positive Data On VB-111 In Advanced Radioactive Iodine Refractory Differentiated Thyroid Cancer At The ITC 2015 Conference

  October 22, 2015

   · 

  8 min read
• Drug Development

  OXiGENE Announces Initiation Of Phase Ib/II Clinical Trial Of Oxi4503 In Acute Myeloid Leukemia

  October 22, 2015

   · 

  3 min read